Product Description
| Download Documents | |
| Product Sheet | |
| SDS | COA-0290961 |
Doxorubicin is an anticancer drug on the World Health Organization's List of Essential Medicines (the most effective and safe medicines needed in a health system). Medical usage of Doxorubicin includes treatment of breast cancer, bladder cancer, kaposi’s sarcoma, lymphoma, and acute lymphocytic leukemia. It intercalates DNA and inhibits macromolecular biosynthesis. This fluorescein-doxorubicin conjugate was first designed and synthesized at CellMosaic® for our customers' usage of detecting doxorubicin or doxorubicin labeled compounds.
The product is sold as 1 vial of 1 mg (Cat#: CM62102-1MG), 5 vials of 1 mg (Cat#: CM62102-5MG), or 10 vials of 1 mg (Cat#: CM62102-10MG). For bulk orders, please contact us for a quote.
Application
- Fluorescent based assay for the quantitation and detection of doxorubicin-labeled biopolymers (ADC and PDC), doxorubicin prodrugs, and free doxorubicin.
- Indirect and competitive ELISA assay.
Chemical Information
- Chemical name: Fluorescein-Doxorubicin conjugate
- Chemical formula: C48H40N2O16S
- Molecular weight: 932.91; CAS number: N/A
Specification
- Physical appearance: orange powder; Storage temp.: -20 °C
- Purity: ≥ 93% by HPLC
